January 2026 – KST Law (in cooperation with Kinstellar) has advised Fareva, a world leader in industrial subcontracting for the pharmaceuticals, cosmetics, and industrial & household sectors, on Turkish law aspects of its entry into a share purchase agreement with Sanofi to acquire a 70% stake in the company operating Sanofi’s pharmaceutical manufacturing facility in Lüleburgaz, Turkey. Sanofi will retain a 30% minority stake in the company.
Completion of the transaction is subject to customary regulatory approvals, including clearance from the Turkish Competition Authority.
The KST Law team worked in close cooperation with lead transaction counsel to Fareva, Linklaters, on the transaction. The KST Law (in cooperation with Kinstellar) team was led by Emre Edmund Özer, Partner and Mert Elçin, Partner.
The team also included Yağmur Ipek Özen, Sıla Saylı, Helin Akbulut, Dilan Cantürk, and Fırat Erin in Corporate/M&A, and Sinan Diniz, Partner and Simru Tayfun, Senior Associate, in Competition/Antitrust & Foreign Investments.